SCHEMBL6311360

SCHEMBL6311360

CCC(O)Cc1c(C)c(C#N)c2nc3ccccc3n2c1N1CC[C@H](N(C)C)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.51
NPSR1 Q6W5P4 5/20 0.51
MEN1 O00255 5/20 0.51
CYP2C9 P11712 2/20 0.49
HIF1A Q16665 1/20 0.49
CYP2C19 P33261 1/20 0.49
TSHR P16473 2/20 0.49
ALDH1A1 P00352 7/20 0.49
HPGD P15428 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KDM4E B2RXH2 4/20 0.47
GLA P06280 2/20 0.47
GAA P10253 2/20 0.47
RXFP1 Q9HBX9 2/20 0.47
LMNA P02545 3/20 0.46
MAPT P10636 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398388 0.89 KMT2A (0.51) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6311130 0.87 HIF1A (0.57) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6314349 0.87 ALDH1A1 (0.50) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6314338 0.86 HIF1A (0.56) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6312844 0.85 L3MBTL1 (0.59) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6309879 0.85 MEN1 (0.57) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6311356 0.85 KMT2A (0.51) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6311693 0.84 ALDH1A1 (0.55) KMT2ANPSR1MEN1CYP2C9HIF1A
Formic Acid SCHEMBL6313188 0.84 NPSR1 (0.54) KMT2ANPSR1MEN1CYP2C9HIF1A
SCHEMBL6312411 0.84 MEN1 (0.51) KMT2ANPSR1MEN1CYP2C9HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KMT2A 4210/4885NPSR1 1531/4885MEN1 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.